GGrantIndex
Sort

326,823 grants matching clinical trial

SECONDARY PREVENTION OF SMALL SUBCORTICAL STROKES (SPS3)

$2,600,119
Oscar R Benavente · University Of British Columbia · U01 · FY2012 · NS

Yale Comprehensive Cancer Center Support Grant

$2,600,006
Charles S Fuchs · Yale University · P30 · FY2017 · CA

Yale Comprehensive Cancer Center Support Grant

$2,600,006
Charles S Fuchs · Yale University · P30 · FY2016 · CA

Yale Comprehensive Cancer Center Support Grant

$2,600,006
Peter G Schulam · Yale University · P30 · FY2015 · CA

Cancer Center Renovation Grant

$2,600,000
University Of Maryland Baltimore · C06 · FY2004 · RR

COPD Clinical Research Network - Data Coordinating Center

$2,600,000
John E Connett · University Of Minnesota · U10 · FY2011 · HL

Cell and Gene Therapy for Nonmalignant Blood Disorders

$2,599,641
Rainer F. Storb · Fred Hutchinson Cancer Research Center · P01 · FY2016 · HL

Phase II trial of GM-CSF/sargramostim in Alzheimer's Disease

$2,599,447
Huntington Potter · University Of Colorado Denver · R01 · FY2023 · AG

University of Virginia Cancer Center Support Grant

$2,599,349
Thomas P Loughran · University Of Virginia · P30 · FY2018 · CA

From therapeutic mechanisms to unraveling the pathophysiology of MS

$2,599,267
Bibiana Bielekova · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI

Univ.of Calif., Irvine Cancer Center Support Grant

$2,599,237
University Of California Irvine · P30 · FY2004 · CA

Targeting epithelial cells to treat pulmonary fibrosis

$2,599,143
Dean Sheppard · University Of California, San Francisco · P01 · FY2012 · HL

Diagnosis, Pathophysiology And Molecular Biology of Pheochromocytoma and Paraganglioma

$2,598,882
Karel Pacak · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2023 · HD

Arterial Stiffness, Cognition, and Equol (ACE)

$2,598,271
Akira Sekikawa · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AG

Advancing the Lives & HeaLth of Youth and Young Adults with Down Syndrome (ALLY-DS)

$2,598,199
Andrea Bridget Kelly · Children'S Hosp Of Philadelphia · U01 · FY2024 · HD

IGF::OT::IGF Support for the Aerosol Development of Bexarotene HHSN2612015000240 TO: HHSN26100004 PoP: 9/18/2017 to 9/17/2019

$2,597,086
David McCormack · Iit Research Institute · N01 · FY2017 · CA

Role of microbiome in cancer and inflammation

$2,596,550
Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Patterns of Survivors' Recovery Trajectories in the ICECAP Trial (POST-ICECAP)

$2,596,407
Sachin Agarwal · Columbia University Health Sciences · R01 · FY2023 · NS

Comparative Oncology Program Laboratory

$2,596,316
Amy Leblanc · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

The Florida Node Alliance of the National Drug Abuse Treatment Clinical Trials Network

$2,596,126
Jose Szapocznik · University Of Miami School Of Medicine · UG1 · FY2016 · DA

Center for Translational Cancer Nanomedicine

$2,596,014
Vladimir P Torchilin · Northeastern University · U54 · FY2010 · CA

Validation of Early Prognostic Data for Recovery Outcomes after Stroke for Future, Higher Yield Trials (VERIFY)

$2,595,998
Pooja Khatri · University Of Cincinnati · U01 · FY2024 · NS

Pharmacogenomics and Risk of Cardiovascular Disease

$2,595,709
Ronald M Krauss · Children'S Hospital & Res Ctr At Oakland · U19 · FY2011 · HL

Diabetes Prevention Program Outcomes Study

$2,595,589
Marinella Temprosa · George Washington University · U01 · FY2014 · DK

Basic and Translational Studies of Inborn Errors of Metabolism

$2,594,935
Forbes Porter · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2025 · HD